tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
TRVI
Trevi Therapeutics
RESEARCH TOOLSreports
Want to see TRVI full AI Analyst Report?

Trevi Therapeutics (TRVI) Income Statement

591 Followers

Trevi Therapeutics Income Statement

Last quarter (Q4 2025), Trevi Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Trevi Therapeutics's net income was $-8.32M. See Trevi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -132.00K$ -147.00K$ 0.00$ 0.00$ -50.00K
Operating Expenses
$ 49.33M$ 51.52M$ 33.92M$ 29.91M$ 32.48M
Depreciation and Amortization
$ 132.00K$ 147.00K$ 123.00K$ 43.00K$ 50.00K
EBITDA
$ -49.33M$ -47.79M$ -28.58M$ -27.98M$ -32.71M
Operating Income
$ -49.33M$ -51.52M$ -33.92M$ -29.91M$ -32.48M
Other Income/Expenses
$ 6.50M$ 3.58M$ 4.83M$ 719.00K$ -1.49M
Pretax Income
$ -42.82M$ -47.94M$ -29.10M$ -29.19M$ -33.96M
Net Income
$ -42.76M$ -47.91M$ -29.07M$ -29.15M$ -33.94M
Per Share Metrics
Basic EPS
$ -0.29$ -0.47$ -0.29$ -0.45$ -1.49
Diluted EPS
$ -0.29$ -0.47$ -0.29$ -0.45$ -1.49
Weighted Average Shares Outstanding
 145.10M 101.04M 99.03M 64.54M 22.84M
Weighted Average Shares Outstanding (Diluted)
 145.10M 101.04M 99.03M 64.54M 22.84M
Currency in USD

Trevi Therapeutics Earnings and Revenue History